Research Diagnosis Related Groups (DRG) level mortality quality outcomes for Moffitt Cancer Center located at 12902 Magnolia Dr, Tampa, FL, 33612 & includes data from NPIs 1780653618
Oct 2016 to Sep 2019 | Oct 2018 to Sep 2019
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 3,169 | 3,054 | ||||||||||||||||||||||
| Surgical | 1,541 | 1,519 | ||||||||||||||||||||||
| Non Surgical | 1,628 | 1,535 | ||||||||||||||||||||||
| General Surgery | 923 | 906 | ||||||||||||||||||||||
| Oncology & Hematology | 515 | 490 | ||||||||||||||||||||||
| General Medicine | 407 | 374 | ||||||||||||||||||||||
| Urology | 407 | 401 | ||||||||||||||||||||||
| Gastroenterology & Endocrinology | 220 | 218 | ||||||||||||||||||||||
| Pulmonology | 195 | 180 | ||||||||||||||||||||||
| Orthopedics | 119 | 119 | ||||||||||||||||||||||
| Colorectal | 112 | 110 | ||||||||||||||||||||||
| Neurology | 70 | 64 | ||||||||||||||||||||||
| Cardiovascular | 64 | 59 | ||||||||||||||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 48 | 47 | ||||||||||||||||||||||
| Obstetrics & Gynecology | 45 | 44 | ||||||||||||||||||||||
| Spine | 36 | 35 |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Chest Procedures | ||||||||||||||||||||||||
| DRG 165: MAJOR CHEST PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 163: MAJOR CHEST PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Craniotomy And Endovascular Intracranial Procedures | ||||||||||||||||||||||||
| DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 027: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Autologous Bone Marrow Transplant Or T-Cell Immunotherapy | ||||||||||||||||||||||||
| DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Pancreas, Liver And Shunt Procedures | ||||||||||||||||||||||||
| DRG 406: PANCREAS, LIVER AND SHUNT PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 407: PANCREAS, LIVER AND SHUNT PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 405: PANCREAS, LIVER AND SHUNT PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Lymphoma And Leukemia With Major Procedure | ||||||||||||||||||||||||
| DRG 822: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Tracheostomy For Face, Mouth And Neck Diagnoses Or Laryngectomy | ||||||||||||||||||||||||
| DRG 012: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 011: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major Procedure | ||||||||||||||||||||||||
| DRG 827: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Allogeneic Bone Marrow Transplant | ||||||||||||||||||||||||
| DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | ||||||||||||||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||||||||||||||
| DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 983: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Major Head And Neck Procedures | ||||||||||||||||||||||||
| DRG 130: MAJOR HEAD AND NECK PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Digestive System O.R. Procedures | ||||||||||||||||||||||||
| Other O.R. Procedures For Injuries | ||||||||||||||||||||||||
| DRG 908: OTHER O.R. PROCEDURES FOR INJURIES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||||||||||||||
| Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Other Procedure | ||||||||||||||||||||||||
| DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Ventricular Shunt Procedures | ||||||||||||||||||||||||
| Non-Extensive Procedure Unrelated To Principal Diagnosis | ||||||||||||||||||||||||
| Adrenal And Pituitary Procedures | ||||||||||||||||||||||||
| DRG 615: ADRENAL AND PITUITARY PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Peritoneal Adhesiolysis | ||||||||||||||||||||||||
| Breast Biopsy, Local Excision And Other Breast Procedures | ||||||||||||||||||||||||
| DRG 585: BREAST BIOPSY, LOCAL EXCISION AND OTHER BREAST PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||||||||||||||
| Other Skin, Subcutaneous Tissue And Breast Procedures |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||||||||||||||
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | ||||||||||||||||||||||||
| DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Chemotherapy | ||||||||||||||||||||||||
| DRG 838: CHEMOTHERPY WITH ACUTE LEUKEMIA AS SDX WITH COMPLICATION OR COMORBIDITY (CC) OR HIGH DOSE CHEMOTHERAPY AGENT | ||||||||||||||||||||||||
| DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Lymphoma And Non-Acute Leukemia | ||||||||||||||||||||||||
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Nervous System Neoplasms | ||||||||||||||||||||||||
| DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Acute Leukemia Without Major Procedure | ||||||||||||||||||||||||
| DRG 834: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Digestive Malignancy | ||||||||||||||||||||||||
| DRG 374: DIGESTIVE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 375: DIGESTIVE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Respiratory Neoplasms | ||||||||||||||||||||||||
| DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||||||||||||||
| DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Red Blood Cell Disorders |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Signs And Symptoms | ||||||||||||||||||||||||
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Complications Of Treatment | ||||||||||||||||||||||||
| DRG 920: COMPLICATIONS OF TREATMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 919: COMPLICATIONS OF TREATMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Cellulitis | ||||||||||||||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Postoperative And Post-Traumatic Infections | ||||||||||||||||||||||||
| DRG 863: POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||||||||||||||
| DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Fever And Inflammatory Conditions | ||||||||||||||||||||||||
| DRG 864: FEVER |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Ureter Procedures | ||||||||||||||||||||||||
| DRG 658: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Major Bladder Procedures | ||||||||||||||||||||||||
| DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 655: MAJOR BLADDER PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Renal Failure | ||||||||||||||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Digestive System Diagnoses | ||||||||||||||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Disorders Of Biliary Tract | ||||||||||||||||||||||||
| DRG 444: DISORDERS OF THE BILIARY TRACT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||||||||||||||
| DRG 372: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 371: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| G.I.Hemorrhage | ||||||||||||||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Endocrine Disorders | ||||||||||||||||||||||||
| G.I. Obstruction |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Pulmonary Embolism | ||||||||||||||||||||||||
| DRG 176: PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||||||||||||||
| Other Respiratory System Diagnoses | ||||||||||||||||||||||||
| Pleural Effusion | ||||||||||||||||||||||||
| Pneumothorax |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||||||||||||||
| Soft Tissue Procedures | ||||||||||||||||||||||||
| Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||||||||||||||
| Biopsies Of Musculoskeletal System And Connective Tissue |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Disorders Of Nervous System | ||||||||||||||||||||||||
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Seizures | ||||||||||||||||||||||||
| Nonspecific Cerebrovascular Disorders |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Circulatory System Diagnoses | ||||||||||||||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stomach, Esophageal And Duodenal Procedures | ||||||||||||||||||||||||
| DRG 327: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 326: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uterine And Adnexal Procedures For Malignancy | ||||||||||||||||||||||||
| DRG 737: UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Pelvic Evisceration, Radical Hysterectomy And Radical Vulvectomy |
| Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2018 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2018 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical With Spinal Curvature / Malignancy / Infection Or Extensive Fusions | ||||||||||||||||||||||||
| DRG 457: SPINAL FUSION EXCEPT CERVICAL WITH SPINAL CURVATURE OR MALIGNANCY OR INFECTION OR EXTENSIVE FUSIONS WITH COMPLICATION OR COMORBIDITY (CC) |